Carbenicillin Treatment of Pseudomonas Pulmonary Infection: Use in Children With Cystic Fibrosis

John P. Phair*, James S. Tan, Chatchai Watanakunakorn, Louis Schwab, Lester W. Sanders

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Thirteen courses of carbenicillin were given to ten children with cystic fibrosis and pulmonary infections due to Pseudomonas aeruginosa. There was clinical improvement following antimicrobial therapy in seven children; however, four children ultimately died. Carbenicillin alone or in combination with polymyxin B sulfate or gentamicin sulfate did not eradicate P aeruginosa from the sputum. There was poor correlation of the clinical result of therapy with the susceptibility of the infecting organism. The only adverse result of carbenicillin administration was a reversible rise in serum glutamic oxaloacetic transaminase and serum glutamic pyruvic transaminase noted during therapy.

Original languageEnglish (US)
Pages (from-to)22-25
Number of pages4
JournalAmerican Journal of Diseases of Children
Volume120
Issue number1
DOIs
StatePublished - Jul 1970

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Carbenicillin Treatment of Pseudomonas Pulmonary Infection: Use in Children With Cystic Fibrosis'. Together they form a unique fingerprint.

Cite this